XML 24 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Thousands, $ in Thousands
CNY (¥)
USD ($)
Secondary Public Offering OR HK IPO
CNY (¥)
Ordinary shares
Class Y Ordinary Shares
CNY (¥)
shares
Ordinary shares
Class Z Ordinary Shares
CNY (¥)
shares
Ordinary shares
Class Z Ordinary Shares
Secondary Public Offering OR HK IPO
CNY (¥)
shares
Additional paid-in capital
CNY (¥)
Additional paid-in capital
Secondary Public Offering OR HK IPO
CNY (¥)
Statutory reserves
CNY (¥)
Accumulated other comprehensive income/(loss)
CNY (¥)
Accumulated deficit
CNY (¥)
Noncontrolling interests
CNY (¥)
Balance at the beginning of the year at Dec. 31, 2019 ¥ 7,636,460     ¥ 53 ¥ 155   ¥ 10,718,190   ¥ 13,463 ¥ 466,229 ¥ (4,145,606) ¥ 583,976
Balance at the beginning of the year (Shares) at Dec. 31, 2019 | shares       85,364,814 242,751,341              
Net loss (3,054,017)                   (3,007,412) (46,605)
Impact of adoption of credit loss guidance (17,900)                   (17,900)  
Share-based compensation 385,898           385,898          
Share issuance from exercise of share options 3       ¥ 3              
Share issuance from exercise of share options (in shares) | shares         4,491,566              
Issuance ordinary shares related to long-term investments 277,467           277,467          
Share issuance from exercise of share options 2,817,458       ¥ 12   2,817,446          
Share issuance from exercise of share options (in shares) | shares         17,310,696              
Shares redesignation       ¥ (1) ¥ 1              
Shares redesignation (in shares) | shares       (1,649,700) 1,649,700              
Accretion to redeemable noncontrolling interests (5,964)           (4,292)         (1,672)
Capital injection in subsidiaries by noncontrolling interests 21,463                     21,463
Acquisition of subsidiaries 162,492           120,865         41,627
Acquisition of subsidiaries (in shares) | shares         270,435              
Appropriation to statutory reserves                 4,421   (4,421)  
Purchase of noncontrolling interests (116,056)       ¥ 1   300,728         (416,785)
Purchase of noncontrolling interests (in shares) | shares         1,731,100              
Foreign currency translation adjustments (325,100)                 (325,100)    
Balance at the end of the year at Dec. 31, 2020 7,782,204     ¥ 52 ¥ 172   14,616,302   17,884 141,129 (7,175,339) 182,004
Balance at the end of the year (Shares) at Dec. 31, 2020 | shares       83,715,114 268,204,838              
Net loss (6,808,739)                   (6,789,228) (19,511)
Share-based compensation 999,817           999,817          
Share issuance from exercise of share options 3       ¥ 3              
Share issuance from exercise of share options (in shares) | shares         3,262,562              
Issuance ordinary shares related to long-term investments         ¥ 1   (1)          
Issuance ordinary shares related to long-term investments (in shares) | shares         1,045,700              
Share issuance from exercise of share options     ¥ 19,266,810     ¥ 18   ¥ 19,266,792        
Share issuance from exercise of share options (in shares) | shares           28,750,000            
Share issuance upon the conversion of convertible senior notes 449,911       ¥ 3   449,908          
Share issuance upon the conversion of convertible senior notes (in shares) | shares         2,854,277              
Capital injection in subsidiaries by noncontrolling interests 2,187                     2,187
Acquisition of subsidiaries 617,999       ¥ 1   632,747         (14,749)
Acquisition of subsidiaries (in shares) | shares         2,056,825              
Appropriation to statutory reserves                 6,737   (6,737)  
Purchase of noncontrolling interests (173,135)       ¥ 1   (35,604)         (137,532)
Purchase of noncontrolling interests (in shares) | shares         715,271              
Foreign currency translation adjustments (420,991)                 (420,991)    
Balance at the end of the year at Dec. 31, 2021 21,716,066     ¥ 52 ¥ 199   35,929,961   24,621 (279,862) (13,971,304) 12,399
Balance at the end of the year (Shares) at Dec. 31, 2021 | shares       83,715,114 306,889,473              
Net loss (7,507,653) $ (1,088,507)                 (7,497,013) (10,640)
Share-based compensation 1,040,683           1,040,683          
Share issuance from exercise of share options 4       ¥ 4              
Share issuance from exercise of share options (in shares) | shares         3,929,433              
Share issuance upon the conversion of convertible senior notes 96           96          
Share issuance upon the conversion of convertible senior notes (in shares) | shares         565              
Repurchase of shares (347,581)       ¥ (2)   (347,579)          
Repurchase of shares (in shares) | shares         (2,640,832)              
Appropriation to statutory reserves                 11,552   (11,552)  
Purchase of noncontrolling interests (in shares) | shares         45,000              
Foreign currency translation adjustments 337,972 49,001               337,972    
Balance at the end of the year at Dec. 31, 2022 ¥ 15,239,587 $ 2,209,533   ¥ 52 ¥ 201   ¥ 36,623,161   ¥ 36,173 ¥ 58,110 ¥ (21,479,869) ¥ 1,759
Balance at the end of the year (Shares) at Dec. 31, 2022 | shares       83,715,114 308,223,639